Abstract

After spinal cord injury (SCI), inflammatory cells such as macrophages infiltrate the injured area, and astrocytes migrate, forming a glial scar around macrophages. The glial scar inhibits axonal regeneration, resulting in significant permanent disability. However, the mechanism through which glial scar-forming astrocytes migrate to the injury site has not been clarified. Here we show that migrating macrophages attract reactive astrocytes toward the center of the lesion after SCI. Chimeric mice with bone marrow lacking IRF8, which controls macrophage centripetal migration after SCI, showed widely scattered macrophages in the injured spinal cord with the formation of a huge glial scar around the macrophages. To determine whether astrocytes or macrophages play a leading role in determining the directions of migration, we generated chimeric mice with reactive astrocyte-specific Socs3−/− mice, which showed enhanced astrocyte migration, and bone marrow from IRF8−/− mice. In this mouse model, macrophages were widely scattered, and a huge glial scar was formed around the macrophages as in wild-type mice that were transplanted with IRF8−/− bone marrow. In addition, we revealed that macrophage-secreted ATP-derived ADP attracts astrocytes via the P2Y1 receptor. Our findings revealed a mechanism through which migrating macrophages attract astrocytes and affect the pathophysiology and outcome after SCI.

Details

Title
Macrophages play a leading role in determining the direction of astrocytic migration in spinal cord injury via ADP-P2Y1R axis
Author
Ono, Gentaro 1 ; Kobayakawa, Kazu 1 ; Saiwai, Hirokazu 1 ; Tamaru, Tetsuya 1 ; Iura, Hirotaka 1 ; Haruta, Yohei 1 ; Kitade, Kazuki 1 ; Iida, Keiichiro 1 ; Kawaguchi, Kenichi 1 ; Matsumoto, Yoshihiro 1 ; Tsuda, Makoto 2 ; Tamura, Tomohiko 3 ; Ozato, Keiko 4 ; Inoue, Kazuhide 5 ; Konno, Dai-Jiro 6 ; Maeda, Takeshi 7 ; Okada, Seiji 8 ; Nakashima, Yasuharu 1 

 Kyushu University, Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Kyushu University, Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); Kyushu University, Kyushu University Institute for Advanced Study, Fukuoka-shi, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Yokohama City University Graduate School of Medicine, Department of Immunology, Kanazawa-ku, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139) 
 NICHD, National Institutes of Health, Program in Genomics of Differentiation, Section on Molecular Genetics of Immunity, Division of Developmental Biology, Bethesda, USA (GRID:grid.420089.7) (ISNI:0000 0000 9635 8082) 
 Kyushu University, Kyushu University Institute for Advanced Study, Fukuoka-shi, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); Kyushu University, Greenpharma Research Center for System Drug Discovery, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Kindai University, Department of Energy and Materials, Faculty of Science and Engineering, Osaka, Japan (GRID:grid.258622.9) (ISNI:0000 0004 1936 9967) 
 Spinal Injuries Center, Department of Orthopaedic Surgery, Iizuka, Japan (GRID:grid.419662.e) (ISNI:0000 0004 0640 6546) 
 Osaka University, Department of Orthopaedic Surgery, Graduate School of Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971) 
Pages
11177
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2835336688
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.